Cases 1 - 8 of 8
Merck Sharp & Dohme LLC v. Biocon Pharma Ltd. et al
as 1:2023cv00683
Plaintiff:
Merck Sharp & Dohme LLC
Defendant:
Biocon Pharma Ltd., Biocon Ltd. and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property GmbH et al v. Biocon Pharma Limited et al
as 1:2023cv00334
Plaintiff:
Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. and others
Defendant:
Biocon Pharma Limited, Biocon Limited and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Biocon Pharma Ltd. et al
as 1:2022cv00937
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Biocon Pharma Ltd., Biocon Ltd. and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Biocon Pharma Ltd. et al
as 1:2022cv00936
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Biocon Pharma Ltd., Biocon Ltd. and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Biocon Pharma Limited et al
as 1:2022cv00726
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Biocon Pharma Limited, Biocon Limited and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CELGENE CORPORATION v. BIOCON PHARMA LIMITED et al
as 2:2021cv11261
Plaintiff:
CELGENE CORPORATION
Defendant:
BIOCON LIMITED, BIOCON PHARMA, INC. and BIOCON PHARMA LIMITED
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
